Celtic fund reaches $100m on way to $700m

Celtic Therapeutics, based in the Virgin Islands, will seek to exploit a ‘crisis’ in the pharmaceutical industry by buying early-to mid-stage drug development programmes. The fund is the successor to Celtic Pharmaceuticals, which reached $400m in commitments and mezzanine funding for investment in drug development programmes.